These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29635685)

  • 1. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review.
    Henze LJ; Koehl NJ; O'Shea JP; Kostewicz ES; Holm R; Griffin BT
    J Pharm Pharmacol; 2019 Apr; 71(4):581-602. PubMed ID: 29635685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food for thought: formulating away the food effect - a PEARRL review.
    O'Shea JP; Holm R; O'Driscoll CM; Griffin BT
    J Pharm Pharmacol; 2019 Apr; 71(4):510-535. PubMed ID: 29956330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
    Van den Bergh A; Van Hemelryck S; Bevernage J; Van Peer A; Brewster M; Mackie C; Mannaert E
    Mol Pharm; 2018 Jul; 15(7):2633-2645. PubMed ID: 29799758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral biopharmaceutics tools: recent progress from partnership through the Pharmaceutical Education and Research with Regulatory Links collaboration.
    O'Dwyer PJ; Box KJ; Dressman J; Griffin BT; Henze LJ; Litou C; Pentafragka C; Statelova M; Vertzoni M; Reppas C
    J Pharm Pharmacol; 2021 Mar; 73(4):437-446. PubMed ID: 33793836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal versus human oral drug bioavailability: do they correlate?
    Musther H; Olivares-Morales A; Hatley OJ; Liu B; Rostami Hodjegan A
    Eur J Pharm Sci; 2014 Jun; 57(100):280-91. PubMed ID: 23988844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling of human oral bioavailability: what will be next?
    Cabrera-Pérez MÁ; Pham-The H
    Expert Opin Drug Discov; 2018 Jun; 13(6):509-521. PubMed ID: 29663836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the Oral Bioavailability Correlation Between Humans and Preclinical Animals.
    Beheshti S; Shayanfar A
    Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):771-783. PubMed ID: 32681440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of pharmacokinetics between humans and monkeys.
    Akabane T; Tabata K; Kadono K; Sakuda S; Terashita S; Teramura T
    Drug Metab Dispos; 2010 Feb; 38(2):308-16. PubMed ID: 19910513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of minipig, dog, monkey and human drug metabolism and disposition.
    Dalgaard L
    J Pharmacol Toxicol Methods; 2015; 74():80-92. PubMed ID: 25545337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
    Poulin P; Jones HM; Jones RD; Yates JW; Gibson CR; Chien JY; Ring BJ; Adkison KK; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Ku MS
    J Pharm Sci; 2011 Oct; 100(10):4050-73. PubMed ID: 21523782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System.
    Martinez MN; El-Kattan A; Awji E; Papich M
    AAPS J; 2019 Aug; 21(5):99. PubMed ID: 31396733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.
    Roth WJ; Kissinger CB; McCain RR; Cooper BR; Marchant-Forde JN; Vreeman RC; Hannou S; Knipp GT
    AAPS J; 2013 Jul; 15(3):763-74. PubMed ID: 23595360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro methods to assess drug precipitation in the fasted small intestine - a PEARRL review.
    O'Dwyer PJ; Litou C; Box KJ; Dressman JB; Kostewicz ES; Kuentz M; Reppas C
    J Pharm Pharmacol; 2019 Apr; 71(4):536-556. PubMed ID: 29956338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species.
    Daublain P; Feng KI; Altman MD; Martin I; Mukherjee S; Nofsinger R; Northrup AB; Tschirret-Guth R; Cartwright M; McGregor C
    Mol Pharm; 2017 May; 14(5):1634-1645. PubMed ID: 28329443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of griseofulvin from plain tablets in Göttingen minipigs and the correlation with bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Yasuda Y; Tanioka Y
    J Pharmacobiodyn; 1984 Jan; 7(1):7-14. PubMed ID: 6726615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.